Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markman

Showing results (101-110 of 545) with videos related to

Pageof 55
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Patient choice, cost, and survival of critically ill cancer patients: a societal dilemmaM Markman
Cleveland Clinic Journal of Medicine|August 18, 2000
Regional delivery of anticancer drugs: current applicationsM Markman
Cancer Investigation|February 7, 2001
Radioimmunoscintigraphy in the management of colorectal and ovarian cancer: does identification improve outcome?M Markman
Cleveland Clinic Journal of Medicine|December 22, 1999
Early recognition of spinal cord compression in cancer patientsM Markman
Gynecologic Oncology|March 30, 2001
Second-line therapy for potentially platinum-sensitive recurrent ovarian cancer: what is optimal treatment?M Markman
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Supportive careM Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2001
Interactions between academic oncology and alternative/complementary/integrative medicine: complex but necessaryM Markman
Expert Review of Anticancer Therapy|July 13, 2002
Intraperitoneal chemotherapy in the management of malignant diseaseM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Cancer genetic risk assessment: a note of cautionM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
A proposal for deciding when to prophylactically administer bone marrow (granulocyte) stimulatory factors to patients receiving cytotoxic chemotherapyM Markman
Pageof 55

Showing results (101-110 of 545) with videos related to

Sort By:
Pageof 55
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Patient choice, cost, and survival of critically ill cancer patients: a societal dilemmaM Markman
Cleveland Clinic Journal of Medicine|August 18, 2000
Regional delivery of anticancer drugs: current applicationsM Markman
Cancer Investigation|February 7, 2001
Radioimmunoscintigraphy in the management of colorectal and ovarian cancer: does identification improve outcome?M Markman
Cleveland Clinic Journal of Medicine|December 22, 1999
Early recognition of spinal cord compression in cancer patientsM Markman
Gynecologic Oncology|March 30, 2001
Second-line therapy for potentially platinum-sensitive recurrent ovarian cancer: what is optimal treatment?M Markman
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Supportive careM Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2001
Interactions between academic oncology and alternative/complementary/integrative medicine: complex but necessaryM Markman
Expert Review of Anticancer Therapy|July 13, 2002
Intraperitoneal chemotherapy in the management of malignant diseaseM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Cancer genetic risk assessment: a note of cautionM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
A proposal for deciding when to prophylactically administer bone marrow (granulocyte) stimulatory factors to patients receiving cytotoxic chemotherapyM Markman
Pageof 55